Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-85.06	-10.12	67.76
Graham Fair Price	489.76	9.05	1.53
PEG	-73.11	< 0.005	-0.03
Price/Book	-64.72	-9.69	27.46
Price/Cash Flow	-66.54	-39.33	-23.62
Prices/Earnings	-71.16	-2.01	6.98
Price/Sales	303.79	92.07	22.80
Price/FCF	-66.54	-39.33	-23.62
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	14.06	0.86	0.75
Operating Margin	-597.06	-9.60	-1.38
ROA	621.96	-0.17	0.02
ROE	0.98	1.20	22.32
ROIC	-0.12	28.63	23153.65
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.59	1.25	-52.87
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.60	-2.25	-277.66
EPS QOQ	2.45	-2.63	7.26
FCF QOQ	-0.61	-0.13	78.80
Revenue QOQ	-0.07	-0.53	-621.34
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	383.79	< 0.005	-100.00
Days Sales Outstanding (DSO)	64.98	100.76	55.06
Inventory Turnover	0.23	3867219.00	1649130739.04
Debt/Capitalization	0.93	-27.48	2859.47
Quick Ratio	2.74	1.36	-50.59
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	0.33	-1.74	433.24
Cash	4.54	4.19	-7.65
Capex	< 0.005	< 0.005	93.03
Free Cash Flow	-0.38	-0.43	-12.98
Revenue	0.39	0.18	-53.41
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.08	1.38	-55.07
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	17.73	-0.49	-97.22
Naive Interpretation	Member

06 - Financial Health · Weak

Rating